These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 13678937)

  • 1. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
    Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA
    J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
    Ellenbogen KA; O'Neill G; Prystowsky EN; Camm JA; Meng L; Lieu HD; Jerling M; Shreeniwas R; Belardinelli L; Wolff AA;
    Circulation; 2005 Jun; 111(24):3202-8. PubMed ID: 15956124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.
    Lerman BB; Ellenbogen KA; Kadish A; Platia E; Stein KM; Markowitz SM; Mittal S; Slotwiner DJ; Scheiner M; Iwai S; Belardinelli L; Jerling M; Shreeniwas R; Wolff AA
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):237-45. PubMed ID: 11584330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tecadenoson: a novel, selective A1 adenosine receptor agonist.
    Peterman C; Sanoski CA
    Cardiol Rev; 2005; 13(6):315-21. PubMed ID: 16230891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.
    Faulds D; Chrisp P; Buckley MM
    Drugs; 1991 Apr; 41(4):596-624. PubMed ID: 1711962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia.
    Parker RB; McCollam PL
    Clin Pharm; 1990 Apr; 9(4):261-71. PubMed ID: 2184971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
    Corino VD; Holmqvist F; Mainardi LT; Platonov PG
    Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
    DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
    Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
    Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.
    Corino VD; Sandberg F; Mainardi LT; Platonov PG; Sörnmo L
    Ann Noninvasive Electrocardiol; 2015 Nov; 20(6):534-41. PubMed ID: 25545540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
    Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
    Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
    Gausche M; Persse DE; Sugarman T; Shea SR; Palmer GL; Lewis RJ; Brueske PJ; Mahadevan S; Melio FR; Kuwate JH
    Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVT-510: a selective A1 adenosine receptor agonist.
    Cheung JW; Lerman BB
    Cardiovasc Drug Rev; 2003; 21(4):277-92. PubMed ID: 14647532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.
    Furlong R; Gerhardt RT; Farber P; Schrank K; Willig R; Pittaluga J
    Am J Emerg Med; 1995 Jul; 13(4):383-8. PubMed ID: 7605518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia].
    Cheng KA;
    Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):773-6. PubMed ID: 14636464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine: an effective and safe antiarrhythmic drug in pediatrics.
    Paul T; Pfammatter JP
    Pediatr Cardiol; 1997; 18(2):118-26. PubMed ID: 9049125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S; Belhassen B; Sheps D; Laniado S
    Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-induced non-sustained polymorphic ventricular tachycardia.
    Romer M; Candinas R
    Eur Heart J; 1994 Feb; 15(2):281-2. PubMed ID: 8005132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia.
    Sager PT; Widerhorn J; Petersen R; Leon C; Ryzen E; Rude R; Rahimtoola SH; Bhandari AK
    Am Heart J; 1990 Feb; 119(2 Pt 1):308-16. PubMed ID: 2301220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous adenosine triphosphate disodium: its efficacy and electrophysiologic effects on patients with paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Pacing Clin Electrophysiol; 1986 May; 9(3):401-10. PubMed ID: 2423982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.